Diagnostic applications for inhibin and activins

Molecular and Cellular Endocrinology

Volumn 359, Issue 1-2, 2012, Pages 121-125

  McNeilly, Alan S ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Activin; Diagnostic applications; Inhibin A; Inhibin B; Reproductive disorders

Indexed keywords

ACTIVIN; ACTIVIN A; INHIBIN; INHIBIN A; INHIBIN ALPHA; INHIBIN B; MYELOPID; UNCLASSIFIED DRUG;

CELL COUNT; DELAYED PUBERTY; DIAGNOSTIC TEST; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOGONADISM; NONHUMAN; OVARY CANCER; OVARY POLYCYSTIC DISEASE; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; SECOND TRIMESTER PREGNANCY; SERTOLI CELL; SPERMATOGENESIS;

ACTIVINS; ANIMALS; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFERTILITY, FEMALE; INHIBINS; MALE; OVARIAN NEOPLASMS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; SPERMATOGENESIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861700105     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.06.017     Document Type: Review

References (71)

1. Aitken D.A., Wallace E.M., Crossley J.A., Swanston I.A., van Pareren Y., van Maarle M., Groome N.P., Macri J.N., Connor J.M. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N. Engl. J. Med. 1996, 334:1231-1236.
2. Anderson R.A., Groome N.P., Baird D.T. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin. Endocrinol. 1998, 48:577-584.
3. Anawalt B.D., Bebb R.A., Matsumoto A.M., Groome N.P., Illingworth P.J., McNeilly A.S., Bremner W.J. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J. Clin. Endocrinol. Metab. 1996, 81:3341-3345.
4. Burger H.G., Hale G.E., Dennerstein L., Robertson D.M. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008, 15:603-612.
5. Cartwright J., Duncan W.C., Critchley H.O.D., Horne A.W. Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities. Reproduction 2009, 138:9-22.
6. Chatzidarellis E., Makrilia N., Giza L., Georgiadis E., Almara C., Syrigos K.N. Effects of taxane-based chemotherapy on ihibin B and gonadotropins as biomarkers of spermatogenesis. Fertil. Steril. 2010, 94:558-563.
7. Coutant R., Biette-Demeneix E., Bouvattier C., Bouhours-Nouet N., Gatelais F., Difresne S., Rouleau S., Lahlop N. Baseline inhibin B and anti-mullerain hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J. Clin. Endocrinol. Metab. 2010, 95:5225-5232.
8. Creus M., Penarrubia J., Fabregues F., Vidal E., Carmona F., Casamitjana R., Vanrell J.A., Balasch J. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum. Reprod. 2000, 15:2341-2346.
9. Crofton P.M., Illingworth P.J., Groome N.P., Stirling H.F., Swanston I., Seth J., McNeilly A.S., Kelner C.J.H. Changes in dimeric inhibin A and B during normal early puberty in boys and girls. Clin. Endocrinol. 1997, 46:109-114.
10. Crofton P.M., Evans A.E.M., Groome N.P., Taylor M.R.H., Holland C.V., Kelner C.J.H. Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin. Endocrinol. 2002, 56:215-221.
11. Dugoff L. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes. Obstet. Gynecol. 2010, 115:1052-1061.
12. Dumesic D.A., Damario M.A., Session D.R., Famuyide A., Lesnick T.G., Thornhill A.R., McNeilly A.S. Ovarian morphology and serum hormone markers as predictors of ovarian follicle recruitment by gonadotrophins for in vitro fertilisation. J. Clin. Endocrinol. Metab. 2001, 86:2538-2543.
13. Dzik A., Lambert-Messerlian G., Izzo V.M., Soares J.B., Pinotti J.A., Seifer D.B. Inhibin B response to EFFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertil. Steril. 2000, 74:1114-1117.
14. Eddie L.W., Baker H.W.G., Higginson R.E., Hudson B. A bioassay for inhibin using pituitary cell cultures. J. Endocrinol. 1979, 81:49-60.
15. Florio P., Abella R.F., de la Torre T., Giamberti A., Luisi S., Butera G., Cazzaniga A., Fri-giola A., Petraglia F., Gazzolo D. Perioperative activin A concentrations as a predictive marker of neurologic abnormalities in children after open heart surgery. Clin. Chem. 2007, 53:282-285.
16. Geerts I., Vergote I., Neven P., Bilen J. The role of inhibins B and antimullerian hormone for diagnosis and follow-up of granulosa cell tumors. Int. J. Gynecol. Cancer 2009, 19:847-855.
17. Gonzalez-Bulnes A., Santiago-Moreno J., Garcia-Garcia R.M., Souza C.J.H., Lopez-Sebastian A., McNeilly A.S. Plasma inhibin A determination at the start of superovulatory FSH treatments is predictive for embryo outcome in goats. Dom. Anim. Endocrinol. 2004, 26:259-266.
18. Groome N.P., Illingworth P.J., O'Brien M., Cooke I., Ganesan T.S., Baird D.T., McNeilly A.S. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin. Endocrinol. 1994, 40:717-723.
19. Groome N.P., Illingworth P.J., O'Brien M., Pai R., Rodger F.E., Mather J., McNeilly A.S. Measurement of dimeric inhibin-B throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 1996, 81:1401-1405.
20. Groome N.P., Illingworth P.J., O'Brien M., Priddle J., Weaver K., McNeilly A.S. Quantification of inhibinPro-aC-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay. J. Clin. Endocrinol. Metab. 1995, 80:2926-2932.
21. Hamada T., Watanabe G., Kokuho T., Taya K., Hasegawa Y., Miyamoto K., Igarashi M. Radioimmunoassay of inhibin in various mammals. J. Endocrinol. 1989, 122:697-704.
22. Healy D.L., Burger H.G., Mamers P., Jobling T., Bangah M., Quinn M., Grant M., Day A.J., Rome R., Campbell J.J. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N. Engl. J. Med. 1993, 329:1539-1542.
23. Hendriks D.J., Kwee J., Mol B.W., te Velde E.R., Broekmans F.J. Ultra-sonography as a tool for the prediction of outcome in IVF patients: a comparative meta analysis of ovarian volume and antral follicle count. Fertil. Steril. 2007, 87:764-775.
24. Horne A.W., van den Driesche S., King A.E., Burgess S., Myers M., Ludlow H., Lourenco P., Ghazal P., Williams A.R., Critchley H.O.D., Duncan W.C. Endometrial inhibin/activin β-B subunit expression is related to decidualization and is reduced in tubal ectopic pregnancy. J. Clin. Endocrinol. Metab. 2008, 93:2375-2382.
25. Illingworth P.J., Groome N.P., Byrd W., Rainey W.E., McNeilly A.S., Mather J.P., Bremner W.J. Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J. Clin. Endocrinol. Metab. 1996, 81:1321-1325.
26. Illingworth P.J., Groome N.P., Duncan W.C., Grant V.E., Tovanobutra S., Baird D.T., McNeilly A.S. Measurement of circulating inhibin forms during the establishment of pregnancy. J. Clin. Endocrinol. Metab. 1996, 81:1471-1475.
27. Jones K.L., Mansell A., Patella S., Scott B.J., Hedger M.P., de Kretser D.M., Phillips D.J. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. PNAS 2007, 104:16239-16244.
28. Klein N.A., Illingworth P.J., Groome N.P., McNeilly A.S., Battaglia D.E., Soules M.R. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J. Clin. Endocrinol. Metab. 1996, 82:2742-2745.
29. Knight P.G., Beard A.J., Wrathall J.H., Castillo R.J.J. Evidence that the bovine ovary secretes 1988. Large amounts of monomeric inhibin alpha subunit and its isolation from bovine follicular fluid. J. Mol. Endocrinol. 1988, 2:189-200.
30. Lapohn R.E., Burger H.G., Bouma J., Bangah M., Krans M., de Bruijn H.W.A. Inhibin as a marker for granulosa cell tumors. N. Eng. J. Med. 1989, 321:790-793.
31. Laporte S., Couto-Silva A.-C., Trabado S., Lemaire P., Brailly-Tabard S., Esperou H., Michon J., Baruchel A., Fischer A., Trivin A., Brauner R. Inhibin B and anti-Mullerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatrics 2011, 11:20-28.
32. Ling N., Ying S.-Y., Ueno N., Esch F., Denoroy L., Guillemin R. Isolation and partial purification of a Mr32,000 protein with inhibin activity from porcine follicular fluid. Proc. Natl. Acad. Sci. USA 1985, 82:7217-7221.
33. Lockwood G.M., Muttukrishna S., Ledger W.L. Inhibins and activins in human ovulation, conception and pregnancy. Hum. Reprod. Update 1998, 4:284-295.
34. Lockwood G.M., Muttukrishna S., Groome N.P., Knight P.G., Ledger W.L. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clin. Endocrinol. 1996, 45:741-748.
35. Lockwood, G.M., Muttukrishna, S., Groome, N.P., Matthews, D.R., Ledger, W.L., 1998. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. J. Clin. Endocrinol. Metab. 83, 1730-1735.
36. Ludlow H., Phillips D.J., Myers M., McLachlan R.I., De Kretser D.M., Allan C.A., Anderson R.A., Groome N.P., Hyvönen M.W., Duncan C., Muttukrishna S. A new 'total' activin B enzyme-linked immunosorbent assay (ELISA): development and validation for human samples. Clin. Endocrinol. 2009, 71:867-873.
37. Magoffin D.A., Jakimuik A.J. Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome. Hum. Reprod. 1998, 13:2693-2698.
38. Mason A.J., Niall H.D., Seeburg P.H. Structure of two human ovarian inhibins. Biochem. Biophys. Res. Commun. 1986, 135:957-964.
39. Matzuk M.M., Lamb D.J. The biology of infertility: research advances and clinical challenges. Nat. Med. 2008, 14:1197-1213.
40. McCullagh D.R. Dual endocrine activity of the testis. Science 1932, 76:19-20.
41. McLachlan R.I., Robertson D.M., Burger H.G., de Kretser D.M. The radioimmunoassay of bovine and human follicular fluid and serum inhibin. Mol. Cell. Endocrinol. 1986, 46:175-185.
42. McNeilly A.S., Swanston I.A., Crow W., Tsonis C.G., Baird D.T. Changes in the plasma concentrations of inhibin throughout the normal sheep oestrous cycle and after the infusion of FSH. J. Endocrinol. 1989, 120:295-305.
43. McNeilly, A.S., Brooks, A.N., Baxter, G., Webb, R., 1994. Sheep adrenal inhibin. In: Burger, H.G., Findlay, J.K., Robertson, D.M., de Kretser, D., Petraglia, F. (Eds.), Frontiers in Endocrinology. Inhibin and Inhibin-Related proteins, vol. 3. pp. 261-269.
44. McNeilly A.S., Souza C.J.H., Baird D.T., Swanston I.A., McVerry J., Crawford J., Cranfield M., Lincoln G.A. Production of inhibin A not B in rams: changes in plasma inhibin A during testis growth and regression and expression of inhibin/activin subunit mRNA and protein in the adult testis. Reproduction 2002, 123:827-835.
45. Miyamoto K., Hasegawa Y., Fukeda M., Nomura M., Igarashi M., Kanagawa K., Matzuo M. Isolation of porcine follicular fluid inhibin at 32 KDaltons. Biochem. Biophys. Res. Commun. 1985, 136:1103-1109.
46. Muttukrishna S., North R.A., Morris J., Schellenberg J.C., Taylor R.S., Asselin J., Ledger W., Groome N., Redman C.W. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum. Reprod. 2000, 15:1640-1645.
47. Muttukrishna S., McGarrigle R., Wakim I., Khadum D.M., Ranieri D.M., Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?. Br. J. Obstet. Gynaecol. 2005, 112:1384-1390.
48. Myers G.M., Lambert-Messerlian G.M., Sigman M. Inhibin B reference data for fertile and infertile men in Northeast America. Fertil. Steril. 2009, 92:1920-1923.
49. Ovarian Cancer, 2011. NHS Nat. Inst. Clin. Excell. CG122.
50. Norman R.J., Milner C.R., Groome N.P., Robertson D.M. Circulating follistatin concentration are higher and activin concentrations are lower in polycystic ovarian syndrome. Hum. Reprod. 2001, 16:668-672.
51. Pigny P., Desailloud R., Cortet-Rudellli C. Serum apha-inhibin levels in polycystic ovary syndrome: relationship to the serum androstenedione level. J. Clin. Endocrinol. Metab. 1997, 82:1939-1943.
52. Radicioni A.f., Anzuini A., de Marco D., Nofroni I., Castracane V.D., Lenzi A. Changes in serum inhibin B during normal male puberty. Eur. J. Endocrinol. 2005, 152:403-409.
53. Ramaswamy S., Marshall G.R., McNeilly A.S., Plant T.M. Evidence that in a physiological setting Sertoli cell number is the major determinant of circulating concentrations of inhibin B in the adult male rhesus monkey (Macaca mulatta). J. Androl. 1999, 20:330-434.
54. Reddy, A., Suri, S., Sargent, I.L., Redman, C.W.G., Muttukrishna, S., 2009. Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-ecalmpsia. PLoS One 4, e-4453.
55. Robertson D.M., Pruysers E., Jobling T. Inhibin as a diagnostic marker for ovarian cancer. Cancer Lett. 2007, 249:14-17.
56. Robertson D.M., Foulds L.M., Leversha L., Morgan F.J., Hearn M.T.W., Burger H.G., Wettenhall R.E.H., de Kretser D.M. Isolation of inhibin from bovine inhibin follicular fluid. Biochem. Biophys. Res. Commun. 1985, 126:220-226.
57. Robertson D.M., Cahir N., Findlay J.K., Burger H.G., Groome N. The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma. J. Clin. Endocrinol. Metab. 1997, 82:889-896.
58. Robertson D.M., Tsonis C.G., McLachlan R.I., Handelsman D.J., Leask R., Baird D.T., McNeilly A.S., Hayward S., Healy D.L., Findlay J.K., Burger H.G., De Kretser D.M. Comparison of inhibin immunological and in vitro biological activities in human serum. J. Clin. Endocrinol. Metab. 1988, 67:438-443.
59. Schneyer A.L., Mason A.J., Burton L.E., Zeigner J.R., Crowley W.F. Immunoreactive inhibin a-subunit in human serum: implications for radioimmunoassay. J. Clin. Endocrinol. Metab. 1990, 70:1208-1212.
60. Sharpe R.M., Turner K.J., McKinnell C., Groome N.P., Atanassova N., Millar M.R., Buchanan D.L., Cooke P.S. Inhibin B levels in plasma of the male rat from birth to adulthood: effect of experimental manipulation of Sertoli cell number. J. Androl. 1999, 20:94-101.
61. Templeton A.A., Morris J.K., Parslow W. Factors that affect the outcome of in vitro fertilization treatment. Lancet 1996, 348:1402-1406.
62. Tsigkou A., Marrelli D., Reis F.M., Luisi S., Silva-Fihlo A.L., Roviello F., Trignelli S.A., Petraglia F. Total inhibin is a potential serum marker for epithelial ovarian cancer. J. Clin. Endocrinol. Metab. 2007, 92:2525-2531.
63. Tsigkou A., Luisis S., De Leo V., Patton L., Gambineri A., Resi F.M., Pasquali R., Petraglia F. High serum concentration of total inhibin in polycystic ovary syndrome. Fertil. Steril. 2008, 90:1859-1863.
64. Tsonis C.G., McNeilly A.S., Baird D.T. Measurement of exogenous and endogenous inhibin in sheep serum using a new and extremely sensitive bioassay for inhibin based on inhibition of ovine pituitary FSH secretion in vitro. J. Endocrinol. 1986, 110:341-352.
65. Tsonis C.G., McNeilly A.S., Baird D.T. Inhibin secretion by the sheep ovary during the luteal and follicular phases of the oestrous cycle and following stimulation with FSH. J. Endocrinol. 1988, 117:283-291.
66. Tsonis C.G., Messinis I.E., Templeton A.A., McNeilly A.S., Baird D.T. Gonadotropic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle. J. Clin. Endocrinol. Metab. 1988, 66:915-921.
67. Veiga-Lopez A., Dominguez V., Souza C.J.H., Garcia-Garcia R.M., Ariznavarreta C., Tresguerres J.A.F., McNeilly A.S., Gonzalez-Bulnes A. Features of follicle-stimulating hormone stimulated follicles in a sheep model: keys to elucidate embryo failure assisted reproductive technique cycles. Fertil. Steril. 2008, 89:1328-1337.
68. Visser J.A., Jong F.H., Laven J.S.E., Themmen A.P.N. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction 2006, 131:1-9.
69. Wallace E.M., Grant V.E., Swanston I.A., Groome N.P. Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome. Prenat. Diagn. 1995, 15:359-362.
70. Wallace E.M., Swanston I.A., McNeilly A.S., Ashby P.J., Blundell G., Calder A.A., Groome N.P. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin. Endocrinol. 1996, 44:17-21.
71. Yong P.A.K., Baird D.T., JooThong K.E., McNeilly A.S., Anderson R.A. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum. Reprod. 2003, 18:35-44.